Anti-Citrullinated Protein Antibodies
"Anti-Citrullinated Protein Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies to citrullinated-peptides and proteins.
|Anti-Citrullinated Protein Antibodies
- Anti-Citrullinated Protein Antibodies
- Anti Citrullinated Protein Antibodies
- Antibodies, Anti-Citrullinated Protein
- Protein Antibodies, Anti-Citrullinated
- Citrullinated Protein Antibodies
- Antibodies, Citrullinated Protein
- Protein Antibodies, Citrullinated
- Anti-Citrullinated Peptide Antibodies
- Anti Citrullinated Peptide Antibodies
- Antibodies, Anti-Citrullinated Peptide
- Peptide Antibodies, Anti-Citrullinated
Below are MeSH descriptors whose meaning is more general than "Anti-Citrullinated Protein Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Anti-Citrullinated Protein Antibodies".
This graph shows the total number of publications written about "Anti-Citrullinated Protein Antibodies" by people in this website by year, and whether "Anti-Citrullinated Protein Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Citrullinated Protein Antibodies" by people in Profiles.
Harrold LR, Shan Y, Connolly SE, Alemao E, Rebello S, Guo L, Kremer JM. Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis. Curr Med Res Opin. 2020 02; 36(2):337-342.
Bergstra SA, Couto MC, Govind N, Chopra A, Salomon Escoto K, Murphy E, Huizinga TW, Allaart CF. Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry. RMD Open. 2019; 5(2):e000969.
Orange DE, Agius P, DiCarlo EF, Mirza SZ, Pannellini T, Szymonifka J, Jiang CS, Figgie MP, Frank MO, Robinson WH, Donlin LT, Rozo C, Gravallese EM, Bykerk VP, Goodman SM. Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol. 2019 07; 71(7):1034-1041.
Baecklund E, Backlin C, R?nnelid J, Toes R, Huizinga T, ?hlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis. Scand J Rheumatol. 2018 07; 47(4):270-275.
Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM. Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-a Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study. J Rheumatol. 2018 01; 45(1):32-39.
Chang HH, Liu GY, Dwivedi N, Sun B, Okamoto Y, Kinslow JD, Deane KD, Demoruelle MK, Norris JM, Thompson PR, Sparks JA, Rao DA, Karlson EW, Hung HC, Holers VM, Ho IC. A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22. JCI Insight. 2016 Oct 20; 1(17):e90045.